Editor

8390 POSTS
0 COMMENTS

Crafting an Particular person Therapy Plan for Sufferers With Prostate Most cancers

In a current interview with CURE, Dr. Curtiland Deville Jr. mentioned the significance of crafting an individualized remedy plan for sufferers with prostate...

Dedication to Sufferers Is Pushed by a Lasting Promise

From left: CHRISTIE GRIFFIN-JONES, MBA-HCM, B.S.N., RN, CPHQ, CRRN, and MIKELA PETTIGREW, B.S.N., RN, OCNMikela Pettigrew, B.S.N., RN, OCN, a medical nurse at...

Understanding the FDA Imfinzi Combo Approval for Bladder Most cancers Care

Adjuvant therapy with Imfinzi (durvalumab) plus chemotherapy, adopted by single-agent, adjuvant Imfinzi following radical cystectomy obtained U.S. Meals and Drug Administration (FDA) approval...

New Choices for ER+ Breast Most cancers Spotlighted at Affected person Occasion

Dr. Brian Czerniecki, of Moffitt Most cancers Heart, led a CURE Educated Affected person® Updates in Metastatic Breast Most cancers occasion, and offered...

Evorpacept With Keytruda Did Not Elicit Responses in Head and Neck Most cancers

Evorpacept and Keytruda didn’t meet the first endpoints of the ASPEN-03 and ASPEN trials, in superior head and neck squamous cell carcinoma.Amongst sufferers...

Editor

8390 POSTS
0 COMMENTS
spot_img